Upload
irina-tarane
View
219
Download
0
Embed Size (px)
Citation preview
8/10/2019 Pancytopenia and Aplastic Anemia Ok
1/33
PancytopeniaandAplastic Anemia
8/10/2019 Pancytopenia and Aplastic Anemia Ok
2/33
Pancytopenia :
Definition The simultaneous presence of
Anemia Leukopenia Thrombocytopenia
Hb< 11.5 g/dL (adult females),< 13.5 g/dL (adult males) WBC < 4x10^9/L (4000/mm3) Plt. < 150 x10^9/L (150.000/mm3 )
8/10/2019 Pancytopenia and Aplastic Anemia Ok
3/33
Causes of Pancytopenia1. Aplastic anemia2. Bone marrow
infiltration by Hematologic
malignancies Non-hematologic Tm
met. Storage cell disorders Osteopetrosis Myelofibrosis
3. Paroxysmal nocturnalhemoglobinuria (PNH)
4. Myelodysplastic syndrome5. Hypersplenism6. Vit B12 or folate
deficiencies7. S. Lupus erythematosus8. Cytotoxic agents and
antimetabolites
9. Radiotherapy10. Overwhelming infections11. other
8/10/2019 Pancytopenia and Aplastic Anemia Ok
4/33
Clinical features
Related to PancytopeniaOr Underlying condition/disease
8/10/2019 Pancytopenia and Aplastic Anemia Ok
5/33
Symptoms/Findings
Related to pancytopenia The presenting symptoms are relatedto anemia or thrombocytopenia
Leukopenia may sometimes be lifethreatining (eg: late in the course ofAA, severe neutropenia)
Anemia develops slowly ( long life spanof RBCs) symptoms of gradual onset.
8/10/2019 Pancytopenia and Aplastic Anemia Ok
6/33
Symptoms/Findings
Related to pancytopenia Thrombocytopenic type bleeding mayoccur and
severity depends on the plt. number.eg: spontaneous bleeding indicatesplt
8/10/2019 Pancytopenia and Aplastic Anemia Ok
7/33
Symptoms/Findings
Related to the cause ofpancytopeniaeg: Splenomegaly : Hypersplenism, lymphoma,
leukemia, myelofibrosis etc
Lymphadenomegaly: Lymphoma ,leukemia,SLE etc Atrophic glossitis: Megaloblastic anemia Others
8/10/2019 Pancytopenia and Aplastic Anemia Ok
8/33
Investigation of Pancytopenia
(Outline) History: Age , sex, occupation, diet Chemical or drug or radiation exposure Bone pain Fever, night sweats , malaise, weight loss
Symptoms related to diseases thatcause splenomegaly
8/10/2019 Pancytopenia and Aplastic Anemia Ok
9/33
Investigation of Pancytopenia(Outline) Physical exam:
Splenomegaly Bone tenderness Hepatomegaly Lymph node enlargement Gingival hypertrophy Signs of liver failure or portal
hypertension Evidence of malignancy
8/10/2019 Pancytopenia and Aplastic Anemia Ok
10/33
Investigation of Pancytopenia(Outline)
Lab. Essential tests
CBC:Pancytopenia Reticulocyte count MCV Peripheral blood smear
Anizocytosis, poikilocytosis, leuko-erythroblastosis
neutrophyl granules, neutrophyl segments, rouleaux formation, atypical cells
Bone marrow exam. (aspiration + biopsy)
8/10/2019 Pancytopenia and Aplastic Anemia Ok
11/33
Investigation of Pancytopenia
(Outline) Lab:
Further investigations when required X-Rays: Bone, chest etc Alk. Phosp, acid. Phosp Serum protein electrophoresis Anti-DNA, FANA, etc Urinary proteins (Bence-Jones) Lymph node or other biopsies
8/10/2019 Pancytopenia and Aplastic Anemia Ok
12/33
Aplastic Anemia (AA)
The term AA is first used by Ehrlichin 1888
Describes a disorder of unknownetiology characterized by pancytopenia with hypo or acellular bone marrow.
It is one of the stem cell disorders.
8/10/2019 Pancytopenia and Aplastic Anemia Ok
13/33
Classification of AA
Fanconis anemia: Autosomal. recessive
inheritance Skeletal and renal defects Hyperpigmentation Small stature Hypogonadism Chromosomal changes
Familial AA (non-Fanconi) Familial but without features
of Fanconis anemia
Dyskeratosiscongenita
Skin, nail and hairabnormalities
Telangiectasia Alopecia Abnormal sweating
Mental retardation Growth failure and
hypogonadism ShwachmanDiamond
syndrome
I-Inherited AA
8/10/2019 Pancytopenia and Aplastic Anemia Ok
14/33
FAOccurrence of Pancytopenia: Age 7(med) 90% up to age 40
Leukemia & other malignancyhepaticsquamous cell carcinomas of the
vulva, oesophagus,head and neck
Important:Chromosomal breakage and hypersensitivity to the
clastogenic effect of DNA cross-linking agentsdiepoxybutane (DEB) and mitomycin C (MMC)
8/10/2019 Pancytopenia and Aplastic Anemia Ok
15/33
Dyskeratosis congenitaAbnormal skin pigmentationNail dystrophyBone marrow failure > 80-90 % up to age 30 LeucoplakiaLearning difficultiesDevelopmental delaymental retardationPulmonary diseaseShort statureExtensive dental caries/lossOesophageal stricturePremature hair loss
MalignancyIntrauterine growth
retardationLiver disease/peptic
ulceration/enteropathyAtaxia/cerebellar hypoplasiaHypogonadism/undescended
testesMicrocephaly
Urethral stricture/phimosisOsteoporosis/asepticnecrosis/scoliosis
Deafness
8/10/2019 Pancytopenia and Aplastic Anemia Ok
16/33
DC genetic subtypes
X-linked recessive 40% (Xq2) Autosomal dominant 5% (3q213q28) Autosomal recessive 50 %
8/10/2019 Pancytopenia and Aplastic Anemia Ok
17/33
ShwachmanDiamond syndrome
Exocrine pancreatic insufficiency (100%), Bone marrow dysfunction (100%) and
Other somatic abnormalities (particularlyinvolving the skeletal system)
SDS gene ( SBDS ) on 7q11
important role in RNA metabolism and/orribosome biogenesis.
8/10/2019 Pancytopenia and Aplastic Anemia Ok
18/33
ShwachmanDiamond syndrome
Short stature (~70%), Ichthyotic skin rash (~60%).
Metaphyseal dysostosis ~75% Other abnormalities include
hepatomegaly,
rib/thoracic cage abnormalities, syndactyly, cleft palate, dental dysplasia, ptosis and skin pigmentation.
8/10/2019 Pancytopenia and Aplastic Anemia Ok
19/33
Classification of AAII-Acquired AA
1. Idiopathic2. Radiation3. Drugs/chemicals
Chloramphenicol NSAID:
(phenylbutasone,indomethacin,gold etc)
Oral hypoglycemic drugs
(chlorpropamide,tolbutamide) Antithyroid drugs,phenothiazines, antimalarials,diuretics,antiepileptics
Antineoplastic andcytotoxic drugs
Pesticides Solvents and glues:
benzene,toluene,xylene,naphtalene
Dyes and industrialtoxins
Others
8/10/2019 Pancytopenia and Aplastic Anemia Ok
20/33
Classification of AA (continued)
4. Infections Hepatitis E.Barr virus
Rubella CMV HIV Parvovirus Brucellosis Tbc Toxoplasmosis
5. Paroxysmal nocturnalhemoglobinuria(PNH)
6. Immunologic disorders SLE, eosinophilic fasciitis Graft- versus- Host Disease Hypoimmunoglobulinemia Thymoma
7. Pregnancy8. Pancreatic insufficiency
8/10/2019 Pancytopenia and Aplastic Anemia Ok
21/33
Epidemiology of AA
A disease of the young Median age: about 25 y
1.5 2 /1.000.000-year Equal sex ratio
8/10/2019 Pancytopenia and Aplastic Anemia Ok
22/33
Pathophysiology
Defective stroma Stem cell damage
Damage to stem cell DNA: Radiation,drugs etc
Later progenitor cell damage: Viruses
Immune mediated Inadequate production of growth
factors?
8/10/2019 Pancytopenia and Aplastic Anemia Ok
23/33
Immune mediated injury Blood and bone marrow of AA patientssupress normal progenitor cell cultures
Cultured AA marrow recovers colonyformation after removal of T-cells
Immunosupressive therapy is effective inabout half of AA patients
Viruses may cause an infection of the stemcell further leading to an immune responseto permanent stem cell failure
8/10/2019 Pancytopenia and Aplastic Anemia Ok
24/33
Clinical Features of AA
History: Bleeding Symptoms of anemia Infections Drugs, chemicals or other etiologically
important exposures have to bequestioned.
8/10/2019 Pancytopenia and Aplastic Anemia Ok
25/33
Clinical Features of AA
Physical exam: Petechiae, ecchymosis Retinal bleeding Pallor Fever and other signs of infection
Presence of lymphadenomegaly and /orsplenomegaly are unusual (indicate otherdiagnoses).
8/10/2019 Pancytopenia and Aplastic Anemia Ok
26/33
Clinical Features of AA
LAB: Pancytopenia Reticulocytes : Low or absent
RBC: normochrome-normocytic,orslight macrocytosis Neutropenia and relative
lymphocytosis Red and white cell precursors are
almost never seen in the peripheralsmear
8/10/2019 Pancytopenia and Aplastic Anemia Ok
27/33
Clinical Features of AA
LAB: PNH tests may be positive (Hams or
sucrose lysis tests,others)
Serum iron is increased Bone marrow :
Aspiration; Dry tap Biopsy; all three cell lines are reduced or
absent, raplaced by fatty tissue, residuallymphocytes, increased iron stores,rarelyhot spots of hematopoesis
8/10/2019 Pancytopenia and Aplastic Anemia Ok
28/33
Course and prognosis of AA
Definition of severe aplastic anaemia: 1- hypocellular bone marrow2-neutrophils
8/10/2019 Pancytopenia and Aplastic Anemia Ok
29/33
Treatment of AA(1)
Treatment alternatives: Allogeneic bone marrow/stem cell
transplantation Immunosupressive treatment Androgens Hematopoietic growth factors Supportive therapy
8/10/2019 Pancytopenia and Aplastic Anemia Ok
30/33
Treatment of AA (2)
Stem cell transplantation: Young patients with severe AA and a
HLA matched donor should undergo astem cell transplantation(minimally transfused patients have achance of > 80% survival )
Risks: GVHD, engraftment failure,other
8/10/2019 Pancytopenia and Aplastic Anemia Ok
31/33
Treatment of AA (3)
Immunosupressive treatment ATG or ALG (antithymosit or
antilymphocytic globulin ) Cyclosporin A Prednisolone(50% chance of recovery ) Risks:
Early:infections Late: MDS, PNH, leukemia, other malignancies,
relapse
8/10/2019 Pancytopenia and Aplastic Anemia Ok
32/33
Treatment of AA (4)Supportive treatment Hemopoetic Growth Factors:
GM-CSF, G-CSF: efficiency ? (limited or not)
Transfusions: Only when indicated Exclude family members as transfusion donors Cellular blood products must be irradiated before
transfusions May cause:Iron overload (Repeated RBCs), alloimmunization, infection transmission(eg : HIV,HCV,HBV,CMVetc),
Infections: Preventive care, early diagnosis and treatment
8/10/2019 Pancytopenia and Aplastic Anemia Ok
33/33
Pure Red Cell Aplasia Anemia + Erythropoetic hypoplasia/aplasia occuring in a
normocellular bone marrowClassification Congenital (Diamond-Blackfan Syndrome) Acquired
During chronic hemolytic anemia (aplastic crisis) Infections(eg: Parvovirus B19) Malnutrition
Drugs (Alpha Methyl Dopa, Azathioprine, Carbamazepine,Gold,NSAID,RMP ,Chloramphenicol etc) Thymoma Malignancy
Idi thi